Recombinant Mouse Antibody (3D6) is capable of binding to APP. It is a neo-epitope specific antibody recognizing amyloid-β1-5 with strong preference for an exposed Asp residue at the N-terminus of the peptide.
Figure 1 Neural Activity Controls Formationof APP Cleavage Derivatives.
Western blots of extracts from organotypic APPSWE slices in the presence of -secretase inhibitor 1 M L-685,458.
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., ... & Malinow, R. (2003). APP processing and synaptic function. Neuron, 37(6), 925-937.
Maniv, Inbal, et al. "Altered ubiquitin signaling induces Alzheimer's disease-like hallmarks in a three-dimensional human neural cell culture model." Nature Communications 14.1 (2023): 5922. https://doi.org/10.1038/s41467-023-41545-7
The study investigates the role of altered ubiquitin signaling in inducing Alzheimer's disease (AD)-like hallmarks using a three-dimensional human neural cell culture model. It highlights that the accumulation of the UBB+1 protein is an early event in Alzheimer's disease. The research demonstrates that UBB+1 expression induces AD pathology in human neurons by interacting with UCHL1 and altering APP protein levels. Notably, silencing UBB+1 expression rescues AD pathology in human familial AD (FAD) neurons.
Creative Biolabs significantly contributed to this study by providing the 3D6 anti-amyloid-β antibody (Cat. no. PABL-011), which was used in immunofluorescence staining experiments. The use of this antibody was crucial for detecting amyloid-β aggregates, a key pathological feature of Alzheimer's disease, thus enabling the researchers to better understand and visualize the AD-like pathology in their 3D neural cell culture model.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
NABG-016 | Recombinant Anti-Human APP VHH Single Domain Antibody | CA, IP, IF, FuncS | Llama VHH |
PNBL-003 | Recombinant Anti-Human APP VHH Single Domain Antibody (PNBL-003) | WB, ELISA, FuncS | Llama VHH |
PNBL-004 | Recombinant Anti-Human APP VHH Single Domain Antibody (PNBL-004) | WB, ELISA, FuncS | Llama VHH |
TAB-0019CL-VHH | Camelid Anti-APP Recombinant Antibody (TAB-0019CL-VHH) | IHC, WB | Camelid VHH |
TAB-0020CL-VHH | Anti-Human APP VHH Single Domain Antibody (TAB-0020CL-VHH) | ELISA, IHC | Single domain antibody |
To accurately reference this product in your publication, please use the following citation information:
(Creative Biolabs Cat# PABL-011, RRID: AB_3111619)
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.